Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products
Authors
Keywords
-
Journal
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 71, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-06
DOI
10.1007/s00005-023-00681-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
- (2022) Zhangfeng Zhong et al. MEDICINAL RESEARCH REVIEWS
- Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
- (2022) Yuze Wu et al. Molecular Cancer
- Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
- (2022) Chiel van Geffen et al. Frontiers in Immunology
- Tillandsia usneoides Extract Decreases the Primary Tumor in a Murine Breast Cancer Model but Not in Melanoma
- (2022) Paola Lasso et al. Cancers
- Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
- (2022) Richard P. Tobin et al. CLINICAL CANCER RESEARCH
- Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion
- (2022) Laura Andrea González Maldonado et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Remodeling tumor microenvironment with natural products to overcome drug resistance
- (2022) Wanlu Zhang et al. Frontiers in Immunology
- Natural products in drug discovery: advances and opportunities
- (2021) Atanas G. Atanasov et al. NATURE REVIEWS DRUG DISCOVERY
- Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
- (2021) Nada S. Aboelella et al. Cancers
- Tumor-related stress regulates functional plasticity of MDSCs
- (2021) Jessica K. Mandula et al. CELLULAR IMMUNOLOGY
- AANG: A natural compound formula for overcoming multidrug resistance via synergistic rebalancing the TGF‐β/Smad signalling in hepatocellular carcinoma
- (2021) Jeff Yat‐Fai Chung et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells
- (2021) Sho Hangai et al. NATURE IMMUNOLOGY
- Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
- (2021) Yanan Li et al. Frontiers in Cell and Developmental Biology
- A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment
- (2021) Francesca Hofer et al. Cells
- Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
- (2021) Zhaonian Hao et al. Biomarker Research
- iNOS regulates the therapeutic response of pancreatic cancer cells to radiation therapy
- (2020) Patricia M.R. Pereira et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
- (2020) Andrew M. K. Law et al. Cells
- Green Tea Polyphenol EGCG Attenuates MDSCs-mediated Immunosuppression through Canonical and Non-Canonical Pathways in a 4T1 Murine Breast Cancer Model
- (2020) Ping Xu et al. Nutrients
- Myeloid Cell-Derived Arginase in Cancer Immune Response
- (2020) Tomasz M. Grzywa et al. Frontiers in Immunology
- Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-κB-IDO pathway
- (2020) Yongyong Wang et al. BIOSCIENCE REPORTS
- Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
- (2020) Lijie Zhai et al. Frontiers in Immunology
- Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
- (2020) Yuhui Yang et al. Frontiers in Immunology
- Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
- (2020) Yang Liu et al. Acta Pharmaceutica Sinica B
- STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1
- (2020) Theresa A. Proia et al. CLINICAL CANCER RESEARCH
- The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
- (2020) Nathan Karin Frontiers in Immunology
- An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma
- (2020) Paola Lasso et al. Frontiers in Immunology
- ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
- (2019) Yu Cao et al. Nature Communications
- Dual blockade of CXCL12-CXCR4 and PD-1–PD-L1 pathways prolongs survival of ovarian tumor–bearing mice by prevention of immunosuppression in the tumor microenvironment
- (2019) Yang Zeng et al. FASEB JOURNAL
- RIP 3 deficiency recruits myeloid‐derived suppressor cells to hepatocellular carcinoma through the CXCL 1‐ CXCR 2 axis
- (2019) Yi‐Ming Li et al. HEPATOLOGY
- Antioxidant Defenses: A Context-Specific Vulnerability of Cancer Cells
- (2019) Jordan A. Cockfield et al. Cancers
- STAT1 inhibits T‐cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma
- (2019) Nathan Ryan et al. INTERNATIONAL JOURNAL OF CANCER
- TIGIT as an emerging immune checkpoint
- (2019) H. Harjunpää et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
- (2019) Bao-Hua Li et al. MOLECULAR IMMUNOLOGY
- CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
- (2019) Joseph A. Flores-Toro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
- (2019) Martha Gschwandtner et al. Frontiers in Immunology
- Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
- (2018) Lifeng Li et al. CANCER RESEARCH
- RSV ameliorates LLC bearing mice development, decreases G-MDSCs accumulation and impairs its suppressive ability
- (2018) Yilin Zhao et al. CANCER SCIENCE
- Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult
- (2018) Tyler J. Loftus et al. CURRENT OPINION IN HEMATOLOGY
- Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders
- (2018) Antero Salminen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Unfolded Protein Response and Cell Fate Control
- (2018) Claudio Hetz et al. MOLECULAR CELL
- Bioactive polysaccharides from natural resources including Chinese medicinal herbs on tissue repair
- (2018) Qiu Li et al. Chinese Medicine
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- A novel MDSC-induced PD-1−PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties
- (2018) Meng Shen et al. OncoImmunology
- VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
- (2018) Liru Wang et al. OncoImmunology
- Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
- (2018) Richard P. Tobin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth
- (2018) Paola Lasso et al. Frontiers in Oncology
- Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells
- (2018) Yasamin Al-Qassab et al. BMC CANCER
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment
- (2018) Jihao Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
- (2018) Aditi Shastri et al. JOURNAL OF CLINICAL INVESTIGATION
- Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
- (2018) Kim Ohl et al. Frontiers in Immunology
- Expression of checkpoint molecules on myeloid-derived suppressor cells
- (2017) Marlene Ballbach et al. IMMUNOLOGY LETTERS
- The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production
- (2017) Colleen S. Netherby et al. JOURNAL OF IMMUNOLOGY
- The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients
- (2017) Richard P. Tobin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- COX2/mPGES1/PGE2pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- (2017) Victor Prima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development
- (2017) Patrick Ming-Kuen Tang et al. Nature Communications
- Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells
- (2017) Zibing Wang et al. OncoImmunology
- CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
- (2017) Jieyao Li et al. OncoImmunology
- Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
- (2017) Jessica C. Hassel et al. OncoImmunology
- Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration
- (2017) Joseph Markowitz et al. Scientific Reports
- Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin
- (2016) Tito A. Sandoval et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Myeloid-derived suppressor cells and proinflammatory cytokines as targets for cancer therapy
- (2016) K.-S. N. Atretkhany et al. BIOCHEMISTRY-MOSCOW
- ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors
- (2016) Jason J. Luke et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden
- (2016) Ke Rui et al. IMMUNOLOGIC RESEARCH
- Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer
- (2016) Dan Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Natural Products as Sources of New Drugs from 1981 to 2014
- (2016) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells’ Subpopulations in the Peripheral Blood of Patients with Non–Small Cell Lung Cancer
- (2016) Filippos Koinis et al. Journal of Thoracic Oncology
- Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- (2016) Emma Eriksson et al. Journal of Translational Medicine
- Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model
- (2016) Yao Lu et al. MOLECULAR THERAPY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- On the origin of myeloid-derived suppressor cells
- (2016) Camilla Rydberg Millrud et al. Oncotarget
- Improving cancer immunotherapy by targeting the STATe of MDSCs
- (2016) Nienke de Haas et al. OncoImmunology
- PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment
- (2016) Tomoaki Iwata et al. Scientific Reports
- Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis
- (2016) Wen-Chi Wei et al. Scientific Reports
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
- (2015) Rachel A. Burga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2015) J. A. Califano et al. CLINICAL CANCER RESEARCH
- Transcriptional regulation of myeloid-derived suppressor cells
- (2015) Thomas Condamine et al. JOURNAL OF LEUKOCYTE BIOLOGY
- All- trans retinoic acid prevents oxidative stress-induced loss of renal tight junction proteins in type-1 diabetic model
- (2015) Eduardo Molina-Jijón et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway
- (2015) Zhongping Fu et al. Oncotarget
- Potential anti-cancer effect of curcumin in human lung squamous cell carcinoma
- (2015) Wei Zhao et al. Thoracic Cancer
- Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
- (2015) Oana Draghiciu et al. OncoImmunology
- Immune system activation through immunogenic cell death and tumor recruitment of dendritic cells is required for anti-tumor activity of a plant-derived polyphenol rich fraction
- (2015) Alejandra Gomez-Cadena et al. Journal for ImmunoTherapy of Cancer
- Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells
- (2015) Bo-Ra Lee et al. Oncotarget
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2014) D. T. Weed et al. CLINICAL CANCER RESEARCH
- The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
- (2014) Paul T. Thevenot et al. IMMUNITY
- Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
- (2014) Daniel W. Beury et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
- (2014) Hong Qin et al. NATURE MEDICINE
- Resveratrol Counteracts Inflammation in Human M1 and M2 Macrophages upon Challenge with 7-Oxo-Cholesterol: Potential Therapeutic Implications in Atherosclerosis
- (2014) Brigitta Buttari et al. Oxidative Medicine and Cellular Longevity
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model
- (2013) Claudia Urueña et al. BMC Complementary and Alternative Medicine
- Effects of Notch Signaling on Regulation of Myeloid Cell Differentiation in Cancer
- (2013) P. Cheng et al. CANCER RESEARCH
- Polyphenol E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells
- (2013) G. Santilli et al. CLINICAL CANCER RESEARCH
- β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells
- (2013) Jie Tian et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells
- (2013) C. Lee-Chang et al. JOURNAL OF IMMUNOLOGY
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
- (2013) Sean M. Geary et al. PLoS One
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
- (2013) Y. P. de Coana et al. Cancer Immunology Research
- Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives
- (2012) Patrick Raber et al. IMMUNOLOGICAL INVESTIGATIONS
- Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cellsin vitroin a TLR4-independent manner
- (2012) Tillmann Michels et al. Journal of Immunotoxicology
- Activated human CD4+ T cells express transporters for both cysteine and cystine
- (2012) Trine Bøegh Levring et al. Scientific Reports
- Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions
- (2011) Junmin Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment
- (2011) Jung-Mi Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Composition and Mechanism of Antitumor Effects ofHericium erinaceusMushroom Extracts in Tumor-Bearing Mice
- (2011) Sung Phil Kim et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Green tea polyphenol sensing
- (2011) Hirofumi TACHIBANA PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Emerging Tim-3 functions in antimicrobial and tumor immunity
- (2011) Kaori Sakuishi et al. TRENDS IN IMMUNOLOGY
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
- (2010) Jennifer S. Ko et al. CANCER RESEARCH
- Mycobacterium bovis Bacillus Calmette-Guérin Vaccination Mobilizes Innate Myeloid-Derived Suppressor Cells Restraining In Vivo T Cell Priming via IL-1R–Dependent Nitric Oxide Production
- (2010) Angelo Martino et al. JOURNAL OF IMMUNOLOGY
- Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
- (2010) Thomas Condamine et al. TRENDS IN IMMUNOLOGY
- Stat 6-Dependent Induction of Myeloid Derived Suppressor Cells After Physical Injury Regulates Nitric Oxide Response to Endotoxin
- (2009) Veronica Munera et al. ANNALS OF SURGERY
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling
- (2009) Carsten Linnemann et al. IMMUNOLOGY
- Oral administration of a soluble 1–3, 1–6 β-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice
- (2009) Ulf Harnack et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Transient depletion of CD4+ T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice
- (2009) Michela Croce et al. INTERNATIONAL JOURNAL OF CANCER
- Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
- (2009) E. M. Hanson et al. JOURNAL OF IMMUNOLOGY
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
- Reversal of Myeloid Cell-Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
- (2008) S. Kusmartsev et al. CLINICAL CANCER RESEARCH
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started